The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...

President Trump signed an executive order Monday that will attempt to bring down the cost of some drugs in the United States ...

Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

President Trump’s executive order to lower drug prices through cross-agency action left pharma leaders scrambling to make ...

CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...